An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

The vaccine has already shown evidence of safety ... a particularly aggressive form of the skin cancer. The five-year survival rate for patients with distant metastatic melanoma remains low ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

As more cancers are being linked to the human papillomavirus (HPV), including cancers showing up in younger-than-average patients, a local doctor is promoting the use of the HPV vaccine, which is ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

Study Identifies Subtypes of Fibroblasts in Skin Cancer Nov. 19 ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep. 13, 2024 — Interim ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.

It also has no reported Guillain-Barré syndrome, which is not the case with the GSK and Pfizer’s RSV vaccines. Secondly, the recent clinical trials show enthusiasm for its skin cancer vaccine.